Effects of Combined Regimens of Gabapentin and Verapamil with Diazepam on Kindled Model of Epilepsy in Mice
Keywords:
Antiepileptic drugs (AED),Diazepam (DZ), Gabapentin(GBP), Verapamil (VP),Pentylenetetrazole(PTZ)Abstract
Objective: To compare the in vivo effects of anticonvulsant combined regimens of Gabapentin / Verapamil with diazepam
on kindled model of Epilepsy in Mice.
Materials and Methods: This experimental study was carried out in Hussain Ebrahim Jamal (H.E.J.) Research Institute of
Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi from May 2009 to July
2011.Gabapentin and Verapamil were used as tested drugs while Diazepam was used as a reference drug. Kindling was produced
by repeated administration of Pentylenetetrazole in a dose of 50 mg/kg by subcutaneous route every 48 hours for 20 days. Six
doses of Gabapentin from 50mg/kg to 300mg/kg and six doses of Verapamil from 5mg/kg to 30mg/kg in combination regimen
were administered by intraperitoneal route. Diazepam was administered by intraperitoneal route in a dose of 7.5mg/kg. Both
tested drugs Gabapentin and Verapamil with reference drug Diazepam were administered once daily, however on the day of
Pentylenetetrazole treatment the tested and reference drugs were injected 40 minutes before injecting Pentylenetetrazole. The
anticonvulsive effects of tested drugs were then compared to reference drug Diazepam.
Results: Combination regimens of Gabapentin and Verapamil exhibited synergistic dose dependent anti- seizure effects up to
100%. The maximum dose of combined regimen exhibited antiseizure effects which were superior to the reference drug
Diazepam.
Conclusion: Combination regimens of Gabapentin and Verapamil showed synergistic effect superior to diazepam on kindled
model of epilepsy in mice.
References
W.H.O, IBE, ILAE, Global Campaign Against Epilepsy, Alas, 2005
Khatria A, Iannacconea ST, Ilyas B M S, Abdullah B M , Saleem S. Epidemiology of Epilepsy in Pakistan: Review of literature. J Pak Med Assoc.2003: 53(12): 594-7
Sheerani M. Development of a comprehensive epilepsy surgery program in Pakistan. J. Pak. Med. Assoc.2005; 55(1): 32-7
Annegers JF, Rocca WA, Hauser WA. Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc. 1996:71(6):570-5
Khosravani H, Zamponi GW. Voltage-gated calcium ch- annels and idiopathic generalized epilepsies. Physiol R- ev. 2006;86(3): 941-66
Khosravani H, Altier C, Simms B, Hamming KS, Snutch TP, Mezeyova J etal. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem. 2004;279(11): 9681-4
Rossetti AO. Treatment options in the management of status epilepticus. Curr Treat Options Neurol. 2010;12 (2):100-12
McTague A, Appleton R. Treatment of difficult epilepsy. Arch Dis Child 2011;96(2):200-4
Summers MA, Moore JL, McAuley JW. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Ann Pharmacother. 2004; 38(10):163 1-4
Wahab A, Albus K, Gabriel S, Heinemann U. In search of models of pharmacoresistant epilepsy. Epilepsia 2010; 51 (Suppl 3):154-9
Dichter MA. Innovative clinical trial designs for future
antiepileptic drugs. Epilepsia 2007; 48 (Suppl 1): 26-
Goa KL, Sorkin EM. Gabapentin: A review of its phar- macological properties and clinical potential in epilepsy. Drugs 1993;46(3):409-27
Beydoun A, Fakhoury T, Nasreddine W, Abou-Khalil B.Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epile- psia1998;39(2):188-93
Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow, Woodruff GN. The novel anticonvulsant drug, Gabapen- tin (Neurontin), binds to the alpha 2 delta subunit of a calcium channel. J Biol Chem. 1996; 271(10): 5768-76
Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F. Addit- ion of Verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res. 2009;85(1): 89-95
Iannetti P, Spalice A, Parisi P.Calcium-channel blocker Verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005;46(6): 967-9
Khosravani H, Zamponi GW. Voltage-gated calcium ch- annels and idiopathic generalized epilepsies. Physiol Rev. 2006;86(3): 941-66
Summers M.A, Moore JL, McAuley JW. Use of Verapa- mil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Pharmacotherapy 2004;38 (10):1631-4
Giordanetto F, Knerr L, Wållberg A. T-type calcium channels inhibitors: a patent review. Expert OpinTher Pat. 2011;21(1):85-101
Fletcher CF. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87.4 1996: 607-17
Miller LC, Drislane FW. Treatment of status epilepticus. Expert Rev Neurother.2008;8(12):1817-27
Abend NS, Dennis J. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatric neurology 38.6 2008 : 377-90
Stefani A,Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacol.1998;37(1): 83-9
Kwan P, Sills GJ, BrodieMJ.The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther. 2001;90(1):21-34
Macdonald R L, Kelly KM. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia. 1994;35 (Suppl 4): S41-S50
Macdonald RL, Kelly KM. Antiepileptic drug mechani- sms of action. Epilepsia.1995;36 (Suppl 2): S2-S12
Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channe- lopathies as a genetic cause of epilepsy. Curr Opin Neurol. 2003;16(2):171-6
Stephen, J, Martin J. Pharmacotherapy of epilepsy CNS drugs 25.2, 2011: 89-107
GlauserT. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndro- mes Epilepsia 47.7 2006; 1094-120
Sills G J. The mechanisms of action of gabapentin and pregabalinCurrent opinion in pharmacology 6.1 2006; 108-13
Holmes GL. Animal model studies application to human patients Neurology 69.24 suppl 3 2007: S28-S32
Borowicz KK. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an is obolographic analysis. Epilepsia 43.9(20- 02): 956-63
White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs Epilepsia 40.s5 (1999): s2-s10
Beydoun A, Fakhoury T, Nasreddine W, Abou-Khalil B. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epile- psia 1998;39(2):188-93
Gracia-Fleta F. Gabapentin in 50 patients with epilepsy. Revista de neurologia 32.1 (2000): 45-9
Ramsay RE.Advances in the pharmacotherapy of epile- psy.Epilepsia 34.s5 (1993): S9-S16
Chadwick D W. A double-blind trial of gabapentin mon- otherapy for newly diagnosed partial seizures .Neurology 51.5 (1998): 1282-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Itefaq Hussain Qureshi, Shabana Usman Simjee
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
